Coltman Ca

1.1k total citations
25 papers, 897 citations indexed

About

Coltman Ca is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Coltman Ca has authored 25 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Hematology. Recurrent topics in Coltman Ca's work include Cancer Treatment and Pharmacology (9 papers), Lymphoma Diagnosis and Treatment (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Coltman Ca is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Lymphoma Diagnosis and Treatment (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Coltman Ca collaborates with scholars based in United States. Coltman Ca's co-authors include Von Hoff, SE Salmon, Donna Stock-Novack, John Crowley, Patrick R. Finley, BG Durie, B Forseth, Jones Se, Muhyi Al‐Sarraf and Balcerzak Sp and has published in prestigious journals such as Blood, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Coltman Ca

25 papers receiving 803 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Coltman Ca	404	320	274	254	184	25	897
Vito Michele Lauta	586 1.5×	498 1.6×	319 1.2×	312 1.2×	110 0.6×	24	1.1k
Bitran Jd	431 1.1×	596 1.9×	272 1.0×	110 0.4×	221 1.2×	33	1.2k
M Weil	446 1.1×	374 1.2×	285 1.0×	222 0.9×	174 0.9×	69	1.1k
G. Ucci	355 0.9×	463 1.4×	357 1.3×	92 0.4×	132 0.7×	61	931
Luigi Salvagno	270 0.7×	121 0.4×	115 0.4×	254 1.0×	119 0.6×	46	618
Gregg A. Olsen	417 1.0×	213 0.7×	79 0.3×	205 0.8×	103 0.6×	17	752
P J Dady	359 0.9×	241 0.8×	124 0.5×	77 0.3×	192 1.0×	25	815
F. R. Appelbaum	287 0.7×	552 1.7×	154 0.6×	273 1.1×	97 0.5×	25	1.1k
Mieczysław Komarnicki	384 1.0×	580 1.8×	483 1.8×	256 1.0×	96 0.5×	97	1.4k
Sheeja T. Pullarkat	508 1.3×	116 0.4×	234 0.9×	272 1.1×	122 0.7×	43	980

Countries citing papers authored by Coltman Ca

Since Specialization

Citations

This map shows the geographic impact of Coltman Ca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coltman Ca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coltman Ca more than expected).

Fields of papers citing papers by Coltman Ca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Coltman Ca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coltman Ca. The network helps show where Coltman Ca may publish in the future.

Co-authorship network of co-authors of Coltman Ca

This figure shows the co-authorship network connecting the top 25 collaborators of Coltman Ca. A scholar is included among the top collaborators of Coltman Ca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Coltman Ca. Coltman Ca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sp, Balcerzak, et al.. (1992). Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenance.. PubMed. 6(7). 708–14. 22 indexed citations

Durie, BG, Donna Stock-Novack, SE Salmon, et al.. (1990). Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study [see comments]. Blood. 75(4). 823–830. 133 indexed citations

Hoff, Von, et al.. (1987). Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group Study.. PubMed. 71(12). 1319–20. 11 indexed citations

Fleming, Thomas R., et al.. (1987). Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.. PubMed. 71(12). 1309–10. 3 indexed citations

Head, David, et al.. (1987). Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group Study.. PubMed. 71(7-8). 713–6. 5 indexed citations

Al‐Sarraf, Muhyi, et al.. (1987). Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study.. PubMed. 71(7-8). 723–6. 52 indexed citations

Ca, Coltman, et al.. (1984). Mitoxantrone in refractory nonHodgkin's lymphoma. A Southwest Oncology Group study.. PubMed. 11(3 Suppl 1). 50–3. 31 indexed citations

Ca, Coltman, et al.. (1982). Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.. PubMed. 66(4). 1023–33. 145 indexed citations

Hoff, Von, et al.. (1982). Long-distance transportation of specimens for human tumor cloning.. PubMed. 2(2). 122–8. 3 indexed citations

10.

Se, Jones, et al.. (1982). Conclusions from clinical trials of the Southwest Oncology Group.. PubMed. 66(4). 847–53. 22 indexed citations

11.

Hoff, Von, Coltman Ca, & B Forseth. (1981). Activity of mitoxantrone in a human tumor cloning system.. PubMed. 41(5). 1853–5. 79 indexed citations

12.

Clark, Gary M., et al.. (1981). Utilization of a human tumor cloning system to monitor for marrow involvement with small cell carcinoma of the lung.. PubMed. 41(3). 1015–20. 24 indexed citations

13.

Ca, Coltman, et al.. (1980). Candidal abscess of the spleen in patients with acute leukemia.. PubMed. 151(5). 604–8. 16 indexed citations

14.

Ca, Coltman, et al.. (1980). Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.. PubMed. 63(9-10). 1605–8. 19 indexed citations

15.

Se, Jones, et al.. (1979). Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(4). 647–53. 37 indexed citations

16.

Ca, Coltman, et al.. (1978). Evaluation of VP-16-213 in malignant lymphoma and melanoma.. PubMed. 62(5). 801–3. 29 indexed citations

17.

Rb, Livingston, et al.. (1978). Adriamycin and chlorambucil versus adriamycin and thiabendazole in the treatment of extensive, non-small cell carcinoma of the lung: a Southwest Oncology Group pilot study.. PubMed. 62(8). 1215–7. 2 indexed citations

18.

Ca, Coltman, et al.. (1977). Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.. PubMed. 61(6). 1067–78. 48 indexed citations

19.

Ca, Coltman, et al.. (1976). Phase II evaluation of cis-diamminedichloroplatinum(II) in lung cancer.. PubMed. 60(11). 1679–80. 31 indexed citations

20.

Ca, Coltman, et al.. (1974). Vinblastine (NSC-49842) and bleomycin (NSC-125066) therapy for disseminated testicular tumors.. PubMed. 58(2). 213–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact